SPCX heads into its August 4 earnings print with a borrow market near shut, short interest at a record, and a Street that cannot agree on whether the stock is worth $115 or $255.
The lending story has not changed — it has deepened. Availability recovered slightly to 4.0% on July 28 after touching a lifetime low of 1.25% the prior session, but that recovery is modest. For every 25 shares already borrowed, just one remains available. Cost to borrow has more than quadrupled over the past month, reaching 4.70% on July 28 — up from below 1% in mid-June. The direction has not reversed once since the IPO. Short interest reached 207.7 million shares on July 28, adding every session since July 10 and now representing 32.5% of the free float. The ORTEX short score has climbed to 69.7, its highest reading since listing. Bears are paying more and still not covering.
Options positioning has moved in the same direction. The put/call ratio has reached 1.00, above its 20-day average of 0.93 and the highest reading in several weeks. That is not a dramatic extreme — the z-score is just under one — but it adds a layer of defensive texture to a stock already surrounded by aggressive short positioning. The setup is one of broad caution rather than one explosive signal.
The analyst picture is the sharpest divergence in the dataset. Ten analysts have initiated or maintained coverage in three weeks. The consensus is Hold, with a mean price target of $231 — roughly double the current price of $116.41. That gap reflects disagreement, not conviction. HSBC initiated on July 24 with a Hold and a $115 target, essentially stamping fair value exactly where the stock trades. Piper Sandler initiated Neutral at $156. Deutsche Bank, Cantor Fitzgerald, Macquarie, RBC Capital, and Needham all rate the stock Buy or Outperform, with targets ranging from $217 to $255. The $140 spread between the most cautious and most bullish targets is unusual for a recently listed stock and suggests the Street is still calibrating a business with limited public financial history. The EV/EBITDA multiple has compressed by roughly 12 turns over the past month to 24.3x — a meaningful re-rating, though the P/E of 194x and P/B near 11x still reflect an elevated valuation premium.
Ownership is heavily concentrated. Elon Musk holds 46% of shares. The next largest institutional holder, Valor Management, holds less than 4%. Baron Capital more than doubled its position last quarter, adding 29 million shares. The rest of the institutional register is thin, which amplifies the significance of every short position — there is limited natural selling pressure from large holders to absorb covering activity, and equally limited buying depth to cushion further declines.
A lockup expiration falls on August 6 — two days after earnings. The sequence matters. The first public financial results arrive before a large pool of pre-IPO holders become eligible to sell. How those numbers land will determine whether August 6 is a pressure release or a further weight on a stock already down 24% from its June peak.
See the live data behind this article on ORTEX.
Open SPCX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
